James B. Renacci sold Sarepta Therapeutics Inc (NASDAQ: SRPT)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 1 trade in Sarepta Therapeutics Inc (SRPT) since 2012, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $15,001 - $50,000 of Sarepta Therapeutics Inc (NASDAQ: SRPT) on August 14, 2012. Since that trade, SRPT is up +84.80% against the S&P 500 up +569.92%, an outperformance of -485.12%.
Data updated
James B. Renacci's SRPT trades vs the price
SRPT is up +84.80% since James B. Renacci sold on August 14, 2012, versus +569.92% for the S&P 500.
Performance since this trade
All James B. Renacci SRPT trades
James B. Renacci & SRPT trading FAQ
Is it legal for James B. Renacci to trade Sarepta Therapeutics Inc (SRPT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Sarepta Therapeutics Inc (SRPT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell SRPT?
James B. Renacci disclosed a sale of $15,001 - $50,000 of Sarepta Therapeutics Inc (SRPT) on August 14, 2012, according to public STOCK Act filings.
How has SRPT performed since James B. Renacci's trade?
Since James B. Renacci sold SRPT on August 14, 2012, the stock is up +84.80%, versus +569.92% for the S&P 500 over the same period, an outperformance of -485.12%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SRPT trades?
Quantellect tracks every disclosed congressional trade in Sarepta Therapeutics Inc (SRPT) on the Sarepta Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's SRPT tradesAll congressional filings for Sarepta Therapeutics IncJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.